ARTICLE | Clinical News
MS-325 injectable contrast agent for MRI: Metasyn's agent is in Phase I testing in healthy volunteers.
October 21, 1996 7:00 AM UTC
Metasyn Inc., Cambridge, Mass. Product: MS-325 injectable contrast agent for MRI Indication: Image blood vessels Status: Metasyn's agent is in Phase I testing in healthy volunteers. The compound is b...